Imunon, Inc.
CLSN
Rankning i aktier
#34919
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Aktiekurs
$1.96
Senast synkroniserad: 2022-09-20
Marknadsvärde
$4.46M
Förändring (1 dag)
0.00%
Förändring (1 år)
122.70%
Land
US
Handel Imunon, Inc. (CLSN)
Kategori
Healthcare
Historik för aktiesplit för Imunon, Inc. (CLSN)
Aktien Imunon, Inc. (symbol: CLSN) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En CLSN-aktie köpt före Oct 21, 2026 motsvarar nu 0 CLSN-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En CLSN-aktie köpt före Oct 21, 2026 motsvarar nu 0 CLSN-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
